The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML.
Blood Cancer J
; 11(6): 111, 2021 06 07.
Article
in En
| MEDLINE
| ID: mdl-34099621
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Fms-Like Tyrosine Kinase 3
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Blood Cancer J
Year:
2021
Type:
Article
Affiliation country:
China